Incidence and risk stratification of pediatric acute respiratory distress syndrome in pediatric intensive care unit.
DOI:
https://doi.org/10.29309/TPMJ/2026.33.03.10223Keywords:
Children, Inotropes, Mechanical Ventilation, Mortality, Oxygenation IndexAbstract
Objective: To determine the incidence and risk stratification of pediatric acute respiratory distress syndrome (PARDS) in mechanically ventilated (MV) patients admitted at the pediatric intensive care unit (PICU). Study Design: Prospective Observational study. Setting: The PICU of National Institute of Child Health, Karachi, Pakistan. Period: April 2024 to March 2025. Methods: A total of 200 children aged 1 month to < 18 years admitted to the PICU with PARDS, and undergoing MV were included. Risk stratification was done on the basis of oxygenation index (OI) categorizing as mild (4 ≤ OI < 8), moderate (8 ≤ OI < 16), and severe (OI ≥ 16). Duration of MV, use of inotropes, PICU stay duration, and mortality were documented and compared with respect to PARDS severity using chi-square test, and Kruskal-Wallis test, taking p<0.05 as significant. Results: Among 200 children, 111 (55.5%) were female, and overall median age was 8.00 (IQR, 4.00–12.00) years. Regarding PARDS categorizations, 24 (12.0%) had mild, 82 (41.0%) moderate, and 94 (47.0%) severe PARDS. Inotropic support was required in 84 (42.0%) patients. Median duration of MV, and PICU stay were 8.00 (5.00–11.00), and 16.00 (12.00–23.00) days, respectively, increasing significantly with severity (p<0.001). Mortality was highest in severe PARDS (21.3%) compared to moderate (2.4%) and mild cases (4.2%) (p<0.001). Conclusion: The PALICC definition and stratification system for PARDS effectively categorize mechanically ventilated pediatric patients into distinct severity groups associated with clinically meaningful differences in ventilator requirements, PICU stay, and mortality.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The Professional Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.